Loading stock data…
Loading stock data…
US$2.31
Get one email when PLYX crosses your level. Checked every 15 minutes during market hours.
▼ -0.10 (-4.15%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
42.0
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.14
Bullish momentumMACD above its signal line (-0.16).
50-day average
2.76
Price belowShort-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Polaryx Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing patient-friendly treatments for lysosomal storage disorders, a group of rare inherited diseases with significant unmet medical need. The company’s current programs center on non-invasive small molecule therapies and a gene therapy candidate designed to address the underlying biology of these disorders. Its pipeline includes orally available approaches aimed at supporting lysosome function, reducing neuroin…
polaryx.com2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-07-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-06-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-05-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-06-23 | 0.34 | 0.41 | ✓ Beat |
| 2026-05-15 | -0.02 | -0.05 | ✗ Miss |
| 2026-04-24 | 1.56 | 1.59 | ✓ Beat |
| 2026-03-24 | -0.02 | -0.16 | ✗ Miss |
| 2026-02-19 | 0.74 | 0.78 | ✓ Beat |
Companies in the same industry, via Finnhub